Univar BV   Report issue

For profit Phase 4
Founded: Seattle WA United States (1924)
Status: No NME R&D (1924)

Organization Overview

First Clinical Trial
2013
NCT01874028
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Univar BV

Active Ingredients

Drugs in Phase 4 Trials (1)

triethylenetetramine (trientine) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatolenticular Degeneration (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 1